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Abstract
Background: Chronic insomnia is among the most reported complaints of Veterans and military personnel referred
for mental health services. It is highly comorbid with medical and psychiatric disorders, and is associated with
significantly increased healthcare utilization and costs. Evidence-based psychotherapy, namely Cognitive Behavioral
Therapy for Insomnia (CBTI), is an effective treatment and recommended over prescription sleep medications. While
CBTI is part of a nationwide rollout in the Veterans Health Administration to train hundreds of providers, access to
treatment is still limited for many Veterans due to limited treatment availability, low patient and provider knowledge
about treatment options, and Veteran barriers such as distance and travel, work schedules, and childcare. Uptake of a
briefer, more primary-care-friendly treatment into routine clinical care in Veterans Affairs (VA) primary care settings,
where insomnia is typically first recognized and diagnosed, may effectively and efficiently increase access to effective
insomnia interventions and help decrease the risks and burdens related to chronic insomnia.
Methods: This hybrid type I trial is composed of two aims. The first preliminarily tests the clinical non-inferiority of Brief
Behavioral Treatment for Insomnia (BBTI) versus the current “gold standard” treatment, CBTI. The second is a qualitative
needs assessment, guided by the Consolidated Framework for Implementation Research (CFIR), to identify potential
factors that may affect successful implementation and integration of behavioral treatments for insomnia in the primary
care setting. To identify potential implementation factors, individual interviews are conducted with the Veterans who
participate in the clinical trial, as well as VA primary care providers and nursing staff.
Discussion: It is increasingly important to better understand barriers to, and facilitators of, implementing insomnia
interventions in order to ensure that Veterans have the best access to care. Furthermore, it is important to evaluate the
potential for new avenues of treatment delivery, like BBTI in the primary care setting, which can benefit Veterans who
may not have adequate access to specialty mental health providers trained in CBTI.
Trial registration: ClinicalTrials.gov, ID: NCT02724800. Registered on 31 March 2016.
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Background
Chronic insomnia—difficulty initiating and maintaining
sleep that persists for more than 3 months—is a prevalent
disorder among adults, approximately 25%, but can be par-
ticularly pervasive among military personnel and Veterans,
with estimates nearing 75% in some samples [1–5].
Chronic insomnia is among the most reported complaints
of Veterans [6] and is the most common initial complaint
of military personnel referred for mental health services [1,
7]. Potential risk factors include deployment overseas, en-
gaging in combat, 24 hours/7 days a week work schedules,
adjusting to separation from military and reintegration to
civilian life, as well as the numerous medical and mental
health problems that commonly affect military personnel
and Veterans [8–13]. It is also a risk factor for the develop-
ment of depression [14] and metabolic and cardiovascular
diseases [15]. Furthermore, insomnia is associated with sig-
nificant healthcare utilization, and both individual and so-
cietal economic burden [16–19].
Despite the significant impact of insomnia, it remains
undertreated [20]. When identified, it is most often treated
in primary care with pharmacotherapy, rather than the
first-line recommendation, Cognitive Behavioral Therapy
for Insomnia (CBTI) [21, 22]. Pharmacotherapy is associ-
ated with risks of dependence, tolerance, and poorer qual-
ity sleep [23–25], whereas evidence-based psychotherapies
for primary and comorbid insomnia results in better long-
term outcomes, no drug dependence or polypharmacy risk,
and potential cost savings [26, 27]. Based on our experi-
ence, numerous system-, provider-, and patient-level fac-
tors contribute to the gap between the high prevalence of
insomnia and the relatively low use of CBTI, and poten-
tially contribute to the high use of prescription medica-
tions: (1) shortage of CBTI-trained clinicians; (2) treatment
restricted to mental health clinics; (3) insomnia being con-
sidered a symptom of another disorder; (4) lack of patient
and provider knowledge regarding CBTI availability; (5)
barriers to attend appointments such as distance to travel,
work schedule, and childcare; and (6) burdensome dur-
ation and delivery method (CBTI can be six or more in-
person, 45-min sessions).
The Department of Veterans Affairs (VA) nationwide
CBTI rollout, which began in 2011, substantially increased
the number of providers who can deliver evidence-based
treatment with fidelity and helped to increase access to
care. An evaluation of 696 Veterans who participated as
part of the CBTI rollout found that 60% who completed
treatment had insomnia severity reductions, per the In-
somnia Severity Index (ISI), of ≥ 8 points (mean change
20.7 to 10.9), with a pre- to post-treatment Cohen’s d ef-
fect size of 2.3 [28, 29]. While the rollout has been success-
ful to date and continues to train providers, CBTI is still
only being delivered to a fraction of those who could bene-
fit. Thus, in order to increase the viability of cognitive and/
or behavioral insomnia treatments in the VA, it is critical
to not only determine which treatments are most effective,
but also to determine which implementation factors (e.g.,
barriers and facilitators) most impact the uptake of these
treatments by patients and providers in routine clinical
practice. An evidence-based behavioral insomnia treat-
ment that combines brevity (four sessions or fewer), mul-
tiple delivery modalities (in-person and phone), and is
delivered by non-physician, non-sleep-specialist clinicians
may help to overcome barriers associated with the current
standard of care treatment, CBTI. However, the four
weekly sessions of Brief Behavioral Treatment for Insom-
nia (BBTI) [30, 31] (two in-person, two phone calls), fo-
cused on the behavioral aspects of CBTI, have also proven
to be efficacious among Veterans [32], and are potentially
easier to implement in primary care settings because this
approach is shorter and requires less training to deliver
competently. Thus, BBTI could be an ideal intervention
for delivery in the context of co-located, collaborative, in-
tegrated primary care within the VA, which employs a var-
iety of providers of differing training levels.
Uptake of BBTI into primary care could effectively and
efficiently increase access to insomnia treatment and poten-
tially decrease some of the risks and burdens associated
with chronic insomnia. However, it is necessary to deter-
mine whether BBTI offers non-inferior treatment outcomes
to CBTI. Additionally, given that the implementation fac-
tors associated with BBTI and CBTI are not well known, it
is also important to determine whether BBTI experiences
fewer patient-, provider-, and system-level barriers to imple-
mentation than CBTI. Therefore, the current proposal uti-
lizes a hybrid type I research design that includes: (1) a pilot
comparative effectiveness trial of BBTI versus CBTI and (2)
a qualitative needs assessment of healthcare provider- and
Veteran-level implementation factors guided by the Consol-
idated Framework for Implementation Research (CFIR), the
predominant model of implementation factors [33].
Methods
Overview and study design
This project is a hybrid type I, comparative effectiveness
trial that compares BBTI to CBTI. The project is being
conducted at one large, urban VA Medical Center
(VAMC) over a 3-year period and is composed of two
aims. The first aim is a randomized, non-inferiority trial to
compare the effectiveness of BBTI versus CBTI. We
hypothesize that (1) both BBTI and CBTI will significantly
reduce insomnia symptoms, per the ISI, from pre- to post-
treatment and (2) BBTI will be non-inferior to CBTI based
on ISI change scores from pre- to post-treatment. Veterans
with chronic insomnia are randomly assigned to either
BBTI or CBTI with treatment being delivered by licensed
psychologists and assessments at baseline, post-treatment,
3-month follow-up, and 12-month follow-up. See Fig. 1 for
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the Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) guidelines; the full SPIRIT
Checklist is available as Additional file 1. CBTI is a well-
established, evidence-based psychotherapy with broad dis-
semination throughout the VA and is considered the rec-
ommended first-line treatment for insomnia per the
National Institutes of Health and the American College of
Physicians [22, 34]. Treatment outcomes for CBTI typically
include significant reduction of symptoms per the ISI and
Cohen’s d effect sizes > 1 at post treatment [29]. The com-
parison treatment, BBTI, is also effective, with significant
treatment outcomes similar to CBTI in active-duty military
and Veterans’ samples [30, 32]; however, the two have not
yet been compared directly.
The second aim is a qualitative needs assessment, guided
by the CFIR, to identify potential factors that may impact
successful implementation and integration of behavioral
and cognitive behavioral treatments for insomnia in the
primary care setting. Given the under-diagnosis of insom-
nia and subsequent inadequate resources to treat insomnia
with behavioral and cognitive behavioral treatments, the
qualitative needs assessment may identify key perceived
barriers and facilitators to implementing these treatments
in primary care, a setting that may be able to significantly
increase access to treatment, especially when it is not
available in other settings such as mental health and/or
sleep medicine. Individual interviews are conducted with
the Veterans who participate in the clinical trial, as well as
primary care providers and nursing staff.
Procedures, participants, measures, and analyses
by study aim
Aim 1: non-inferiority, comparative effectiveness trial of
CBTI versus BBTI
Data source
Fifty-six Veterans with chronic insomnia will be ran-
domized to either of the two treatment arms, BBTI (ac-
tive comparison) or CBTI (reference treatment).
Recruitment and participants
The target population is a clinical sample of Veterans with
chronic insomnia (see Table 1). Veterans are eligible if they
meet the diagnostic criteria for an insomnia disorder ac-
cording to the Diagnostic and Statistical Manual of Mental
Disorders-5 (DSM-5) and are 18 years of age or older. In
an attempt to be as pragmatic and reflective of typical clin-
ical samples, exclusionary criteria were limited to key fac-
tors that would likely prevent a Veteran from engaging in
similar treatments for insomnia in a typical VA setting.
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CBTI X X X X X
BBTI X P X P
Assessments:
ISI X X X X X X X/M X/M X/M
Sleep Diaries X X X X X X X/M X/M X/M
PSQI X X/M X/M X/M
DBAS X X/M X/M X/M
ESS X X/M X/M X/M
PHQ-9 X X/M X/M X/M
GAD-7 X X/M X/M X/M
PCL-5 X X/M X/M X/M
Fatigue X X/M X/M X/M
Global Health X X/M X/M X/M
WSAS X X/M X/M X/M
Notes: X, in person; P, phone; M, mail
Fig. 1 Schedule of enrollment, interventions, and assessments
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significantly increase their risk of experiencing side effects
with standard treatment or would require a significant
adaptation of treatment. Veterans are also excluded con-
sistent with the standard of care for cognitive and/or be-
havioral treatment of insomnia at the study VAMC.
Screening process
The screening interview, conducted by the study coordin-
ator, includes gathering Veteran information regarding:
demographics (age, sex, and Veteran status); clinical infor-
mation, including a brief description of sleep complaint
and the ISI (≥15, indicative of at least moderately severe
insomnia); exclusionary DSM-5 diagnoses (e.g., psychotic
disorders); known medical and sleep disorders; and
current alcohol and drug use. This information is used to
determine preliminary eligibility and those Veterans who
are eligible are invited to a face-to-face visit to complete
informed consent, a brief cognitive screen, a diagnostic as-
sessment for sleep and psychiatric disorders, and collec-
tion of baseline measures. Ineligible Veterans, if interested,
are referred to an appropriate clinic (e.g., behavioral health,
sleep medicine, insomnia clinic). Once a participant is
screened, they are assigned a unique study identification
number that is used on all study documents in order to
maintain confidentiality.
Baseline screening measures and assessments
The initial face-to-face visit includes answering Veterans’
questions and addressing concerns, and administering
written informed consent and baseline assessments and
measures. The study coordinator administers written in-
formed consent and conducts the baseline assessment
unless otherwise indicated.
In order to assess for insomnia disorder, inclusionary cri-
teria, as well as other sleep disorders that may be exclu-
sionary, the STRONG STAR Clinical Interview for DSM-5
Sleep-Wake Disorders (DSM-5-SW [35]) is used. The
STRONG STAR Interview, developed by the South Texas
Research Organizational Network Guiding Studies on
Trauma and Resilience (STRONG STAR), was developed
to assess for all DSM-5 Sleep-Wake disorders, including:
insomnia, hypersomnia, circadian rhythm disorders, ob-
structive sleep apnea, restless leg syndrome, periodic limb
movements, parasomnias, nightmares, rapid eye move-
ment (REM) sleep behaviors, and narcolepsy. To further
screen for the presence of untreated obstructive sleep
apnea, participants are administered the STOP-BANG
Questionnaire [36], which is an eight-item self-report
screening tool for obstructive sleep apnea, scored yes/no.
Scores range 0–8 with scores ≥ 5 indicative of high risk of
moderate-to-severe obstructive sleep apnea. Questions ask
about snoring, daytime sleepiness, blood pressure, Body
Mass Index, age, neck circumference, and gender. Vet-
erans scoring ≥ 5 are excluded from the study until further
assessed by the study VAMC Sleep Medicine Clinic for
sleep apnea or other breathing-related sleep disorders.
Veterans with suspected non-insomnia sleep disorders are
also referred to the Sleep Medicine clinic for further as-
sessment. In the event that the Sleep Medicine Clinic
evaluation rules out non-insomnia sleep disorders, the par-
ticipant is eligible for the study.
To screen for potential exclusionary cognitive impair-
ment, the St. Louis University Mental Status Examination
(SLUMS [37]) is administered. The SLUMS is a brief cog-
nitive impairment screening tool, validated in Veterans.
Domains include: orientation; short-term memory recall;
executive function; attention, concentration, and working




ISI≥ 15 (moderately severe insomnia) and DSM-5 criteria for insomnia
disorder
Exclusion criteria
Current/past bipolar disorder or seizure disorder, and current
psychotic disorder in order to avoid potential exacerbation of manic/
hypomanic, seizure, and psychotic symptoms, respectively, as adverse
reactions to aspects of BBTI/CBTI (e.g., sleep restriction)
Current alcohol use disorder or substance use disorder as BBTI/CBTI
cannot reverse the adverse effects of substances on sleep
Other current, severe or unstable, psychiatric and medical disorders
that necessitate clinical management that can confound results (e.g.,
cancer [receiving chemotherapy], suicidality, recent hospitalization
[medical/surgical] for which recovery overlaps with study onset and
duration, open skull/brain injury, moderate to severe traumatic brain
injury)
Previously diagnosed sleep apnea that is not adequately treated or
probable sleep apnea (STOP-BANG≥ 5)
Moderate to severe cognitive impairment (SLUMS≤ 20) and/or
diagnosis in the medical record indicative of moderate-to-severe
cognitive impairment
If using a sleep medication, the medication and dose has changed in
the past month and/or is expected to change during the treatment
phase of the study
If using other psychotropic medication, medication and dose has
changed in the past 2 months and/or are expected to change during
the treatment phase of the study
The following are exclusionary as they represent (potentially)
temporary states/situations that may significantly impair normal sleep:
Women who are pregnant and/or breast feeding
Unstable environment that is not in one’s control (e.g., homeless,
temporary group home, care-taking duties at night)
Shift work: severe delayed sleep phase disorder (e.g., habitual bedtime
after 4 a.m. or habitual rise time after 11 a.m.)
Restless leg syndrome with symptoms > 2 times per week and
causing significant distress
BBTI Brief Behavioral Treatment for Insomnia, CBTI Cognitive Behavioral
Therapy for Insomnia, DSM Diagnostic and Statistical Manual of Mental
Disorders, ISI Insomnia Severity Index, SLUMS St. Louis University Mental
Status Examination
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memory; semantic fluency; and visuospatial ability. A
score ≤ 20, indicative of serious cognitive impairment or
dementia, results in exclusion from the study.
In order to establish the presence of psychiatric disor-
ders as baseline participant characteristics and also as
potential variables to include in analyses, participants
are administered the Structured Clinical Interview for
DSM-5 Research Version (SCID-5-RV [38]). The SCID-
5-RV is a semi-structured interview guide for diagnosing
DSM-5 disorders. It includes the major diagnostic cat-
egories and the diagnostic elements needed for inclusion
and exclusion criteria. Assessing for a broad range of
psychiatric disorders helps to better characterize the
sample. The study principal investigator (PI), a licensed
psychologist, conducts the SCID-5-RV assessment.
Outcome measures
The primary sleep outcome is the Insomnia Severity Index
(ISI [39]). The ISI is a seven-item self-report measure of
subjective insomnia severity, satisfaction with sleep, and
daytime impairment. Items are rated 0–4; a cutoff of ≥ 15
points reflects clinically significant insomnia and is the
minimum score to be eligible for participation. At post
treatment, a reduction of ≥ 8 points indicates a moderate
response to treatment; a score ≤ 7 points indicates no clin-
ical insomnia and combined with a reduction of ≥ 8 points
indicates treatment remission. The ISI is also administered
at all in-person treatment sessions for both treatment arms.
Since sleep is a multidimensional behavior, several add-
itional self-report measures are used as secondary out-
comes to assess changes pre to post treatment. We use
Sleep Diaries [40] to measure sleep behaviors such as sleep
onset latency (SOL), wake after sleep onset (WASO), sleep
efficiency (SE), nighttime awakenings (NWAK), time in bed
(TIB), total sleep time (TST), as well as to monitor bed
times and wake times throughout treatment. The Dysfunc-
tional Beliefs and Attitudes about Sleep (DBAS [41]) mea-
sures changes in sleep-disruptive cognitions and beliefs
across treatment. The Pittsburgh Sleep Quality Index (PSQI
[42]) is a measure of general sleep quality and the Epworth
Sleepiness Scale (ESS [43]) measures daytime sleepiness.
Additional secondary outcome measures focus on self-
reported psychiatric, psychosocial, and quality of life
parameters. Psychiatric symptoms are assessed with the
Patient Health Questionnaire 9 (PHQ-9 [44]) for depres-
sive symptoms, the Generalized Anxiety Disorder 7 (GAD-
7 [45]) for anxiety symptoms, and the PTSD Checklist for
DSM-5 (PCL-5 [46]) for symptoms of posttraumatic stress
disorder. Fatigue is measured by the Patient-Reported Out-
come Measurement Information System (PROMIS) fatigue
scale [47]. The PROMIS Global Health Scale [48] measures
overall quality of life and the Work and Social Adjustment
Scale (WSAS) [49] measures psychosocial functioning.
Each of these outcome measures is administered at
baseline, post-treatment, 3-month follow-up, and 12-
month follow-up (see Fig. 1). To the extent possible, the
research team attempts to collect outcome measures at the
appropriate time points for all participants, even those
who drop out of treatment.
Randomization
Following the diagnostic assessment and confirmation of
eligibility, 56 Veterans are randomized in a 1:1 manner
to the two treatment groups, BBTI (N = 28) or CBTI (N
= 28). Randomization is at the patient level, stratified by
age (18–64, 65 + years) and if taking a prescription seda-
tive hypnotic medication (yes/no), with a 1:1 allocation
using random block sizes of 2, 4, or 6. Assignments are
generated by the study statistician and placed in opaque,
sealed envelopes. The study coordinator is responsible
for informing the Veterans of their treatment group as-
signment. The study PI is blinded to participant alloca-
tion but may need to be unblinded for clinical reasons
(e.g., participant dropout and seeking clinical referral for
treatment).
Clinical interventions
CBTI [50] is a structured treatment that addresses sleep-
related behaviors and cognitions; it is effective in reducing
insomnia severity and improving sleep quality, and is the
standard non-pharmacological treatment for insomnia in
VA. As part of this study, CBTI consists of five in-person
sessions (weekly or biweekly) and is delivered by two li-
censed psychologists, trained in CBTI. The behavioral as-
pects of the treatment include sleep restriction (to increase
the sleep drive and consolidate sleep through decreasing
SOL and WASO) and stimulus control (to strengthen the
bed as a cue for sleep and remove non-sleep stimuli from
the bedroom environment) and may also include relaxation
exercises (to reduce physiological arousal). The cognitive
component focuses on restructuring or changing maladap-
tive sleep-related cognitions, such as thoughts that increase
cognitive arousal and beliefs that interfere with adherence
to the behavioral aspects of insomnia treatment.
BBTI [51] is a structured treatment that focuses on
sleep-related behaviors and is effective for the treatment of
insomnia. The behavioral aspects of the treatment, similar
to those in CBTI, have been shown empirically to improve
sleep quality through sleep restriction and stimulus con-
trol. Unlike CBTI, there are no cognitive components to
treatment. BBTI is delivered over four consecutive weeks,
consisting of two in-person sessions (weeks 1 and 3) and
two phone sessions (weeks 2 and 4). The therapist manual
and participant workbook were adapted for Veterans from
the initial treatment protocols [51]. Treatment is delivered
by two licensed psychologists, trained in BBTI.
Study clinicians are rated for treatment fidelity and com-
petency using the CBTI rating scale from the VA CBTI
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Therapist Manual. BBTI clinicians are rated on an adapted
rating scale. Treatment sessions are rated based on audio-
recordings on a monthly basis with a random sample of
each clinician rated. If study clinician’s ratings are below
the cut-off (<28, CBTI; <22, BBTI) the study PI provides
additional training to the clinician. Discontinuation from
treatment is voluntary per the participant or if deemed
clinically indicated by the study clinicians.
Follow-up assessments
The self-report measures assessed at baseline are repeated
following the end of their intervention (post treatment), at
3-months post-treatment, and again at 12-months post-
treatment.
Hypothesis
We hypothesize that both BBTI and CBTI significantly
reduce insomnia symptoms, per the ISI, from pre- to
post-treatment. We also hypothesize that BBTI is a non-
inferior (i.e., similar) treatment to CBTI based on ISI
change scores from pre- to post-treatment.
Data analysis
To test the effectiveness of BBTI and CBTI, using an “in-
tent-to-treat” approach, we will fit a linear mixed model
that tests for the main effects of treatment group (BBTI
versus CBTI) and time (baseline, post-treatment, 3-month,
and 12-month follow-ups) as well as the interaction of
treatment and time. A secondary analysis of treatment
effectiveness includes calculating the rates of treatment
response and remission, and calculating the number
needed to treat (NNT) for BBTI and CBTI [30]. To deter-
mine treatment non-inferiority, the 95% confidence interval
(CI) of the mean ΔISI for the BBTI group is compared to a
non-inferiority margin (NIM) [52, 53]. If the 95% CI is en-
tirely to the right of the NIM, we will have shown non-
inferiority [54]. The non-inferiority margin (NIM) repre-
sents the maximum acceptable difference between ΔISIBBTI
and ΔISICBTI.
Power analysis
To achieve adequate power (power = 0.80, α = 0.05), a sam-
ple size of n = 42 (n = 21 per group) at post-treatment was
determined using methods appropriate for non-inferiority
trials [55]. Estimation of sample size was informed by the
Reliable Change Index (RCI [56]), which was calculated
using data from the VA CBTI rollout, a nationwide effort
to train providers in the VA to deliver CBTI [29]. The RCI
is a metric to help determine if the magnitude of change
(e.g., pre- to post-treatment) is statistically reliable. For this
comparative effectiveness trial, RCI represents the change
on the ISI from pre- to post-treatment (CBTI) that
would be expected by chance. An RCI > 1.96 indicates that
the post-test score likely reflects real change (versus the
pre-test score) and the change is not due to chance [56].
The RCI used for power analysis, based on the pre- to
post-CBTI ΔISI, was RCI = 3.43. In order to reach n = 42,
our goal is to randomize 56 Veterans (n = 28/group) given
that we are estimating 25% withdrawal/dropout after
randomization (based on the VA CBTI rollout [28, 29] and
BBTI clinical trials [30, 32]).
Aim 2: qualitative needs assessment to identify perceived
barriers to, and facilitators of, implementation
Data source
Primary care providers, primary care nurses, and Vet-
erans (from aim 1).
Recruitment and participants
The target sample is 8–12 primary care providers (physi-
cians, physician assistants, and nurse practitioners) and 8–
12 primary care nurses (registered nurse care managers
and licensed practical nurses) from the study VAMC who
treat patients with chronic insomnia. We use purposive
sampling so that we can gather a range of perspectives
from healthcare providers involved in the care process and
Veterans involved in the clinical trial. To the best of our
ability, we use the typical case strategy in order to highlight
the general experience of primary care providers and
nurses who treat patients with insomnia [57]. We also plan
to use the snowball strategy so that those who we recruit
and interview can help us identify additional similar pro-
viders and nurses in primary care who would also be in-
formative [57]. These types of providers are targeted as
they represent the front-line clinicians that Veterans typic-
ally engage with and report various health problems and
symptoms to, including difficulty sleeping. It is valuable to
know these providers’ thoughts, opinions, and perspectives
in order to identify and better understand perceived bar-
riers to, and facilitators of, implementation and to help im-
prove access to care. Recruitment methods of primary care
providers and nurses include invitation to participate by
the PI based on established relationships through his work
as a primary care-mental health integration psychologist.
Also, primary care leadership is assisting with recruitment
through the broad invitation to providers and nurses to
participate in the research study by email. Also targeted for
recruitment are 8–12 Veterans from each treatment group
in aim 1 who completed at least one treatment session.
Similar to the providers, the feedback from Veterans en-
gaged in treatment will provide useful information to help
improve access to care. However, the Veteran interview
will differ from the provider interview with a focus on their
experiences in treatment, opinions and perspectives on the
treatment not received, and preferences for care. The goal
of recruiting 8–12 per group is to achieve thematic satur-
ation, when data collection and analysis reveals no new
themes [58]. If thematic saturation is not achieved with 8–
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12 participants in each group, then we will continue with
interviews until saturation is reached [58]. The study co-
ordinator or other research staff administers written in-
formed consent; the study coordinator, research staff, or PI
conducts the qualitative interviews.
Measures and data collection
As mentioned above, the goal of this qualitative needs as-
sessment is to identify perceived barriers to, and facilitators
of, implementing behavioral treatment of insomnia into
the primary care setting. Guiding the discovery and evalu-
ation of implementation barriers is the CFIR [33]. The
CFIR was developed with the specific goal of improving
Veteran healthcare by implementing research findings into
routine clinical practice. It is advantageous for initial imple-
mentation efforts as it combines numerous implementa-
tion theories and can be applied across a broad range of
domains. CFIR is organized into five domains, each with
numerous factors that may influence successful implemen-
tation; the five domains are: (1) intervention characteristics,
including the strength and quality of treatments; (2) outer
settings such as external policies and incentives to integrate
treatment; (3) inner settings such as the culture of a clinic;
(4) individual characteristics such as self-efficacy to engage
in, and benefit from, treatment; and (5) the implementation
process such as engagement of clinic providers in using a
treatment. The CFIR domains and factors act as a guiding
framework for implementation research.
The basic structure of the interview guide for the
primary care providers and nurses is to introduce them to
the basics of BBTI and CBTI and then ask a series of open-
ended questions and discussion items related to CFIR
factors, assessing any perceived barriers to, or facilitators
of, implementing brief treatments for insomnia in the pri-
mary care setting. Veteran interviews focus on their experi-
ence in treatment, how it can further be improved, as well
as a discussion about the treatment they received versus
the treatment they did not.
Hypothesis
There are no specific a priori hypotheses. However, the
goal of this qualitative aim is to identify potential provider-
and Veteran-level factors, using a CFIR-guided qualitative
needs assessment, which may impact successful implemen-
tation and integration of behavioral and cognitive behav-
ioral treatments for insomnia in the primary care setting
and help to improve access to care.
Data analysis
Using a constant comparative approach, data collection and
analysis will be concurrent. Coding will use the Editing
Style [59], which involves an open iterative coding approach
that will allow for identification of basic concepts related to
the CFIR factors as well as any additional factors that arise.
As each interview is conducted and transcribed, transcripts
are reviewed by two coders to identify emergent themes
and develop preliminary codebooks based on CFIR coding
methods; a codebook will be developed for the providers
and nurses and a separate codebook for Veterans [60]. The
process involves two coders reading each transcript a num-
ber of times to familiarize themselves with the content and
categorize the data. The coders will compare newly gath-
ered and previously collected data to identify emergent
concepts, categories, themes and relationships in the data
and develop an initial set of codes to be applied to subse-
quent transcripts. As additional transcripts are examined,
codes are operationally defined, refined, and agreed upon
by the coders. Similar or related codes are collapsed and
large codes will, when needed, be separated into more re-
fined and conceptually precise codes. The focus is on iden-
tifying specific perceived barriers to, and facilitators of,
successful implementation using the CFIR domains and
factors. The provider and nurse codebook, and the Vet-
eran codebook are finalized after review of the first four to
six transcripts per cohort (providers, nurses, and Vet-
erans); however, we will remain receptive to potential new
codes emergent in remaining transcripts [61]. Once the
codebooks are compiled and consensus is reached for
each cohort, the finalized codebooks are independently
applied to all transcripts by the two coders. Throughout
codebook development and the coding process, the two
coders meet to compare coding and resolve any discrep-
ancies through negotiated consensus [62]. A study team
member and expert qualitative methodologist serves as an
adjudicator to ensure codebook development consistency
and help resolve coding conflicts. Final analysis will allow
us to identify common themes within the groups (i.e., pro-
vider/nurse and Veteran).
Discussion
As CBTI continues to be disseminated to providers across
the VA, it is increasingly important to better understand
barriers to, and facilitators of, successful implementation of
insomnia treatment in order to ensure that Veterans have
the best access to care. Furthermore, it is important to
evaluate the potential for new avenues of treatment deliv-
ery, like BBTI, that can benefit Veterans who may not have
adequate access to specialty mental health providers
trained in CBTI. As described above, this hybrid type I pro-
ject preliminarily tests the clinical non-inferiority of a
briefer, primary care-friendlier treatment, BBTI, versus the
current “gold standard” treatment for insomnia, CBTI. Fur-
thermore, utilizing CFIR-guided qualitative interviews with
primary care providers and nurses, this project also seeks
to identify key perceived barriers to, and facilitators of,
implementing BBTI, or similar treatments, into the primary
care setting in order to improve access to care. For Vet-
erans, the interviews will help to understand their
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experiences in care and their care preferences. These are
two of the strengths of this hybrid type I project.
Additionally, if the clinical trial is successful, and BBTI
is shown to be non-inferior to CBTI, there may be a path-
way toward broader training of BBTI as a complementary
treatment to CBTI, with training focused on primary care
staff like nurses and social workers, especially in settings
where psychologists are not easily accessible or available
(e.g., community-based outpatient clinics). Alternatively,
even if BBTI is not found to be non-inferior to CBTI,
there are still several directions to pursue. For example, if
BBTI is not non-inferior to CBTI but still results in a sig-
nificant treatment response for some Veterans, BBTI may
still be appropriate for widespread dissemination and play
an important role in stepped-care treatment for insomnia
throughout VA. Also, by conducting a hybrid trial, the
process of implementing high-quality, evidence-based
practices, like BBTI, may be accelerated by the valuable
input gained through qualitative interviews with both pro-
viders and Veterans. The qualitative interviews afford the
participants the opportunity to provide in-depth informa-
tion about their perspectives and insights about improving
access to care, including advantages, disadvantages, and
ways to succeed and the potential pitfalls to avoid from
the frontline clinicians, and the open-ended interview
structure allows for participant-directed responses. The
perspectives of providers and Veterans on how to success-
fully implement BBTI into primary care settings can help
guide the development of methods around identified bar-
riers. Lastly, our multidisciplinary team has the broad
spectrum of health services expertise needed to conduct
this research, including health psychology, behavioral
sleep medicine, implementation science, and qualitative
and quantitative methods. The team members can make a
substantive contribution to what is known about the im-
plementation of behavioral treatments for insomnia in the
primary care setting and improving access to care for Vet-
erans with chronic insomnia.
While this study has potential to improve access to care
for Veterans with chronic insomnia, it is not without limi-
tations. The study site is a single, urban VAMC that is cur-
rently adequately staffed to manage its Veterans with
insomnia. This may limit the generalizability of results for
both study aims, not only among other VAMCs but also
for the general community. Conducting a multisite hybrid
trial may have helped to solve these limitations and may
be an appropriate design for future studies to confirm, ex-
pand, or explore alternatives based on the current study’s
findings. In regards to limitations of qualitative research,
the goal is not generalizability in a statistical sense, but it
is important to assess the ability of the proposed research
to generate findings with utility beyond merely describing
the specific study settings and sample. Qualitative research
has been shown to produce fine-grained and rich
descriptive analysis not achievable with purely quantitative
approaches, and generate hypotheses and theoretical in-
sights that can be usefully extrapolated, tested, and imple-
mented beyond the specific study settings and sample.
Given the current lack of empirical data on BBTI versus
CBTI as well as implementing brief behavioral treatments
into the primary care setting, we argue that a qualitative
approach to identifying providers’ perceived barriers to,
and facilitators and Veterans’ experiences of, treatment
and preferences for care, is well justified and will make a
significant contribution to the existing knowledge base.
We have chosen to include a primary care providers (i.e.,
physicians, physician assistants, and nurse practitioners),
nurses (registered nurse care managers and licensed prac-
tical nurses), and Veterans in hopes of increasing variation
in the perspectives of valuable stakeholders and maximiz-
ing our ability to identify a more exhaustive list of barriers
to, and facilitators of, implementation.
CBTI currently has significant support as the recom-
mended first-line treatment for chronic insomnia for adults
[34]. Still, there is much work to be done to provide effect-
ive and accessible insomnia care to Veterans, as well as the
general community, and the results of this hybrid study
may help reach those goals.




VAPHS Institutional Review Board (IRB) approval for this
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